# Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT

> **NCT04862676** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Rochester** · enrollment: 29 (actual)

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** Hyperbaric oxygen

## Key facts

- **NCT ID:** NCT04862676
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-22
- **Primary completion:** 2025-04-04
- **Final completion:** 2025-06-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04862676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04862676, "Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04862676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*